Opus Genetics (IRD) Non-Current Debt (2025 - 2026)

Opus Genetics (IRD) has reported Non-Current Debt for 2 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Non-Current Debt changed N/A year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (changed N/A YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
• Non-Current Debt advanced to $1.2 million in Q1 2026 per IRD's latest filing, from $1.1 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $1.2 million in Q1 2026 and bottomed at $1.0 million in Q2 2025.